Home › Funds › Atom Investors LP › SGMT
Atom Investors LP position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Atom Investors LP reported holding 725,924 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$7.2M, representing 0.49% of its reported portfolio and ranking #25 among its reported holdings. Atom Investors LP has disclosed SGMT holdings in 3 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's SGMT position evolved
Atom Investors LP first disclosed a stake in SGMT in Q2 2025 at 20,393 shares (US$155K). The position peaked in Q3 2026 at 725,924 shares, worth US$7.2M. Across 3 filings, Atom Investors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 725,924 shares valued at US$7.2M — an increase of 379,906 shares quarter over quarter.. Notable position changes include a 110% increase in Q3 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 20.39K | $155.40K | New |
| Q2 2026 | 346.02K | $2.67M | New |
| Q3 2026 | 725.92K | $7.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), Affinity Asset Advisors, LLC (US$25.0M), Saturn V Capital Management LP (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 3.75M sh · $37.01M · Q3 2026
- Affinity Asset Advisors, LLC 2.53M sh · $24.97M · Q3 2026
- Saturn V Capital Management LP 2.00M sh · $19.79M · Q3 2026
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Spruce Street Capital LP 1.40M sh · $13.83M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Jones Hill Capital LP 502.59K sh · $4.97M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 423.01K sh · $4.18M · Q3 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held SGMT?
Atom Investors LP has disclosed SGMT holdings in 3 of the last 6 reported quarters, going back to Q2 2025.
What is Atom Investors LP's current position in SGMT?
As of Q3 2026, Atom Investors LP holds 725.92K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $7.17M, representing 0.49% of its reported portfolio and ranking #25.
Has Atom Investors LP been buying or selling SGMT?
In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in SGMT. The position peaked in Q3 2026 at 725.92K shares.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, Affinity Asset Advisors, LLC, Saturn V Capital Management LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.